Innodem Neuroscience is the maker of Pigio, an app that uses AI-powered mobile software technology to allow paralyzed or intubated patients to communicate with eye movements. Users will be able to control a cursor on the screen with their eye movements and select pre-defined sentences and words displayed on the screen, which will then produce an audio output.

Neurotrack is a digital medicine solution for Alzheimer's disease, giving people direct access to the scientifically validated digital diagnostic and therapeutic to delay or prevent memory health conditions.

RightEye is a health technology company using eye tracking for patient care. RightEye leverages scientific research and a patented, cloud-based software platform to deliver eye movement tests and therapies. RightEye's eye tracking platform allows for early and accurate detection of issues, including concussions, traumatic brain injuries, autism, reading, general eye health, performance vision, and Parkinson's disease, and other movement disorders.

NeuraLight is building an AI-driven platform to accelerate and improve drug development and patient monitoring, as well as introduce precision care for patients with neurological disorders using oculometric data captured with a standard webcam or smartphone. The company is focusing on Alzheimer’s, Parkinson’s Disease, ALS, and Multiple Sclerosis. Pharmaceutical and biotech companies, academic research institutions, clinical centers, patient advocacy groups, and other organizations promoting solutions for treatment of neurodegenerative diseases partner with NeuraLight to transform the lives of people impacted by neurological disorders through digitizing evaluation and care. NeuraLight was founded in 2021 and is based in Tel Aviv, Israel.